Connection

Joseph Jenrette to Middle Aged

Back to Details
This is a "connection" page, showing publications Joseph Jenrette has written about Middle Aged.
Joseph Jenrette
Connection Strength
0.355
Middle Aged
  1. Rosai-Dorfman disease: management of CNS and systemic involvement. Clin Adv Hematol Oncol. 2012 Mar; 10(3):199-202.
    View in: PubMed
    Score: 0.029
  2. Central nervous system myelomatosis with optic neuropathy and intramedullary spinal cord compression responding to radiation therapy. Jpn J Radiol. 2011 Aug; 29(7):513-6.
    View in: PubMed
    Score: 0.028
  3. Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn J Radiol. 2010 Jun; 28(5):385-7.
    View in: PubMed
    Score: 0.025
  4. Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. Am J Surg. 2010 Feb; 199(2):204-9.
    View in: PubMed
    Score: 0.024
  5. High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol. 2009 Jul; 93(3):343-8.
    View in: PubMed
    Score: 0.023
  6. Late chest wall toxicity after MammoSite breast brachytherapy. Brachytherapy. 2009 Jan-Mar; 8(1):19-25.
    View in: PubMed
    Score: 0.023
  7. Patient satisfaction and quality of life after MammoSite breast brachytherapy. Am J Surg. 2008 Oct; 196(4):545-8.
    View in: PubMed
    Score: 0.023
  8. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):305-9.
    View in: PubMed
    Score: 0.022
  9. The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8.
    View in: PubMed
    Score: 0.022
  10. Radiation therapy for palliation of Eisenmenger's syndrome-associated painful splenomegaly. Radiat Med. 2008 Feb; 26(2):84-7.
    View in: PubMed
    Score: 0.022
  11. Delayed skin toxicity in MammoSite breast brachytherapy. Am J Clin Oncol. 2006 Dec; 29(6):645-6.
    View in: PubMed
    Score: 0.020
  12. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy. 2005; 4(4):259-63.
    View in: PubMed
    Score: 0.017
  13. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539. J Neurosurg. 2018 07; 129(1):35-47.
    View in: PubMed
    Score: 0.011
  14. Ultrasound-guided tandem placement for low-dose-rate brachytherapy in advanced cervical cancer minimizes risk of intraoperative uterine perforation. Ultrasound Obstet Gynecol. 2011 Feb; 37(2):241-4.
    View in: PubMed
    Score: 0.007
  15. Glioneuronal tumor with neuropil-like islands of the spinal cord with diffuse leptomeningeal neuraxis dissemination. J Neurooncol. 2011 Sep; 104(2):529-33.
    View in: PubMed
    Score: 0.007
  16. Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):21-9.
    View in: PubMed
    Score: 0.006
  17. A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. J Neurosurg. 2010 Aug; 113(2):192-8.
    View in: PubMed
    Score: 0.006
  18. Helical tomotherapy for extramedullary hematopoiesis involving the pericardium in a patient with chronic myeloid leukemia. Jpn J Radiol. 2010 Jul; 28(6):476-8.
    View in: PubMed
    Score: 0.006
  19. Mammographic surveillance after MammoSite breast brachytherapy: analysis of architectural patterns and additional interventions. Am J Clin Oncol. 2007 Dec; 30(6):574-9.
    View in: PubMed
    Score: 0.005
  20. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007 Jun 01; 68(2):354-8.
    View in: PubMed
    Score: 0.005
  21. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery. 2006 Apr; 58(4):701-9; discussion 701-9.
    View in: PubMed
    Score: 0.005
  22. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys. 2005 Jan 01; 61(1):169-74.
    View in: PubMed
    Score: 0.004
  23. Outcome of radiation therapy for renal transplant rejection refractory to chemical immunosuppression. Radiother Oncol. 2005 Jan; 74(1):17-9.
    View in: PubMed
    Score: 0.004
  24. Interparenchymal hemorrhagic neurocytoma: an atypical presentation of a rare CNS tumor. Med Pediatr Oncol. 1999 Jun; 32(6):440-6.
    View in: PubMed
    Score: 0.003
  25. Dynamic stereotactic radiosurgery: the Charleston program: a report on the first 150 patients. J S C Med Assoc. 1998 May; 94(5):218-21.
    View in: PubMed
    Score: 0.003
  26. Combined modality therapy in the treatment of epidermoid carcinoma of the anus at the Medical University of South Carolina. J S C Med Assoc. 1993 Jul; 89(7):333-6.
    View in: PubMed
    Score: 0.002
  27. Primary malignant extragonadal germ cell tumors. An analysis of the effect of the effect of radiotherapy. Cancer. 1990 Jun 15; 65(12):2681-5.
    View in: PubMed
    Score: 0.002
  28. Epidermoid carcinoma of the anus. Surg Gynecol Obstet. 1982 Nov; 155(5):745-51.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.